Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2008

  • 31 Oct 2008

    Quarterly Report 30 September 2008

  • 13 Oct 2008

    Presentation to Annual General Meeting

  • 13 Oct 2008

    Resolutions Passed at Annual General Meeting

  • 15 Sep 2008

    Annual Report for year ended 30 June 2008 and Notice of Annual General Meeting

  • 9 Sep 2008

    BIT225 Highly Synergistic with New Class of Anti-HCV Therapies

  • 29 Aug 2008

    Year End Accounts and Preliminary Final Report for year ended 30 June 2008

  • 14 Aug 2008

    Biotron Expands HCV Clinical Trial to a Second Site

  • 8 Aug 2008

    Change of Address Details

  • 7 Aug 2008

    Phase Ib/IIa HCV Clinical Trial Commenced

  • 23 Jul 2008

    Quarterly Report 30 June 2008

  • 22 May 2008

    Underwriting Agreement – New Issue Announcement

  • 9 May 2008

    May 2008 edition of BITNews

  • 22 Apr 2008

    Quarterly Report 31 March 2008

  • 31 Mar 2008

    Underwriting Agreement – New Issue Announcement

  • 11 Mar 2008

    Presentation of Biotron’s HIV and HCV Programs at International Partnering Meeting

  • 21 Feb 2008

    Half-year report 31 December 2007

  • 30 Jan 2008

    Quarterly Report 31 December 2007

  • <<
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy